January 2025 MCAS Recording (NOT Eligible for CEU unless attended live)
If you are not a member of AND-STL, purchase a downloadable recording of our January meeting! Please note this session is ONLY CDR-approved for CEU credit if attended live. Those who registered / attended the session have been provided a complimentary copy of this recording. Please reach out to andstlcorrespondence@gmail.com if you attended the live session and need this re-sent to you.
Topic: MCAS: Diagnosis, Medical Treatment, and Diet
Presented By: Dr. Leonard B. Weinstock
Mast cell activation syndrome is a common, yet rarely known disease by physicians and the general population. Accordingly, patients suffer for decades and see specialists after specialists. Physicians often remain in their own silo of medical skills and rarely see the big picture. Diet plays a big role in therapy.
Learning Objectives of Presentation:
MCAS symptoms
Cause and triggers for MCAS
Treatment of MCAS: role of medicine and diet
Dr. Leonard B. Weinstock is Board Certified in Gastroenterology and Internal Medicine. He is president of Specialists in Gastroenterology and the Advanced Endoscopy Center. He is an Associate Professor of Clinical Medicine and Surgery at Washington University School of Medicine. He is a primary investigator at two research centers. Dr. Weinstock received a BA Magna Cum Laude from University of Vermont and his medical degree from University of Rochester School of Medicine. He completed postgraduate training and was chief resident in Internal Medicine at Rochester General Hospital. His Gastroenterology Fellowship was performed at Washington University School of Medicine.
Dr. Weinstock is an active lecturer and has published more than 140 articles, abstracts, editorials, book chapters, and poster presentations at national meetings. He is currently researching the role of mast cell activation syndrome, Long COVID, small intestinal bacterial overgrowth, restless legs syndrome, and rosacea. Dr. Weinstock has extensive expertise with low dose naltrexone (LDN) in multiple inflammatory and autoimmune conditions. His research has been presented in national and international conferences and online interviews. Further information and a complete CV are available at www.gidoctor.net .
If you are not a member of AND-STL, purchase a downloadable recording of our January meeting! Please note this session is ONLY CDR-approved for CEU credit if attended live. Those who registered / attended the session have been provided a complimentary copy of this recording. Please reach out to andstlcorrespondence@gmail.com if you attended the live session and need this re-sent to you.
Topic: MCAS: Diagnosis, Medical Treatment, and Diet
Presented By: Dr. Leonard B. Weinstock
Mast cell activation syndrome is a common, yet rarely known disease by physicians and the general population. Accordingly, patients suffer for decades and see specialists after specialists. Physicians often remain in their own silo of medical skills and rarely see the big picture. Diet plays a big role in therapy.
Learning Objectives of Presentation:
MCAS symptoms
Cause and triggers for MCAS
Treatment of MCAS: role of medicine and diet
Dr. Leonard B. Weinstock is Board Certified in Gastroenterology and Internal Medicine. He is president of Specialists in Gastroenterology and the Advanced Endoscopy Center. He is an Associate Professor of Clinical Medicine and Surgery at Washington University School of Medicine. He is a primary investigator at two research centers. Dr. Weinstock received a BA Magna Cum Laude from University of Vermont and his medical degree from University of Rochester School of Medicine. He completed postgraduate training and was chief resident in Internal Medicine at Rochester General Hospital. His Gastroenterology Fellowship was performed at Washington University School of Medicine.
Dr. Weinstock is an active lecturer and has published more than 140 articles, abstracts, editorials, book chapters, and poster presentations at national meetings. He is currently researching the role of mast cell activation syndrome, Long COVID, small intestinal bacterial overgrowth, restless legs syndrome, and rosacea. Dr. Weinstock has extensive expertise with low dose naltrexone (LDN) in multiple inflammatory and autoimmune conditions. His research has been presented in national and international conferences and online interviews. Further information and a complete CV are available at www.gidoctor.net .
If you are not a member of AND-STL, purchase a downloadable recording of our January meeting! Please note this session is ONLY CDR-approved for CEU credit if attended live. Those who registered / attended the session have been provided a complimentary copy of this recording. Please reach out to andstlcorrespondence@gmail.com if you attended the live session and need this re-sent to you.
Topic: MCAS: Diagnosis, Medical Treatment, and Diet
Presented By: Dr. Leonard B. Weinstock
Mast cell activation syndrome is a common, yet rarely known disease by physicians and the general population. Accordingly, patients suffer for decades and see specialists after specialists. Physicians often remain in their own silo of medical skills and rarely see the big picture. Diet plays a big role in therapy.
Learning Objectives of Presentation:
MCAS symptoms
Cause and triggers for MCAS
Treatment of MCAS: role of medicine and diet
Dr. Leonard B. Weinstock is Board Certified in Gastroenterology and Internal Medicine. He is president of Specialists in Gastroenterology and the Advanced Endoscopy Center. He is an Associate Professor of Clinical Medicine and Surgery at Washington University School of Medicine. He is a primary investigator at two research centers. Dr. Weinstock received a BA Magna Cum Laude from University of Vermont and his medical degree from University of Rochester School of Medicine. He completed postgraduate training and was chief resident in Internal Medicine at Rochester General Hospital. His Gastroenterology Fellowship was performed at Washington University School of Medicine.
Dr. Weinstock is an active lecturer and has published more than 140 articles, abstracts, editorials, book chapters, and poster presentations at national meetings. He is currently researching the role of mast cell activation syndrome, Long COVID, small intestinal bacterial overgrowth, restless legs syndrome, and rosacea. Dr. Weinstock has extensive expertise with low dose naltrexone (LDN) in multiple inflammatory and autoimmune conditions. His research has been presented in national and international conferences and online interviews. Further information and a complete CV are available at www.gidoctor.net .